Nine of a Doctor's 10 Children Are Killed in Israel's Latest Strikes in Gaza
CAIRO (AP) — The bodies of 79 people killed by Israeli strikes have been brought to hospitals in the past 24 hours, Gaza 's Health Ministry said Saturday — a toll that doesn't include hospitals in the battered north that it said are now inaccessible.
The dead over the past day in Israel's renewed military offensive included nine of a doctor's 10 children, colleagues and the Health Ministry said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
an hour ago
- Associated Press
The Church of Jesus Christ strengthens global effort, doubling initial projections, helping improve the lives of more than 21 million women and children worldwide
SALT LAKE CITY , June 6, 2025 /PRNewswire/ -- As part of its ongoing responsibility to care for those in need, The Church of Jesus Christ of Latter-day Saints is bolstering its global initiative to improve the well-being of women and children. During meetings on Temple Square in Salt Lake City, Utah, on Thursday, June 5, 2025, Relief Society General President Camille N. Johnson told representatives from eight global humanitarian organizations that the Church is donating another US$63.4 million to this worldwide project first announced in 2023. Last year, the Church announced a $55.8 million donation as part of this effort. 'Collaboration remains at the heart of this initiative; we create the greatest impact through our united efforts. Together, we look forward to another year of creating healthier futures for women and children and strengthening communities,' President Johnson said. During the gathering, representatives shared key results from 2024, highlighting significant progress: The Church has taken a leadership role in convening eight globally recognized nonprofits, and as part of four groups, each focused on projects benefiting women and children. These organizations are: CARE International, Catholic Relief Services (CRS), Helen Keller Intl, iDE, MAP International, Save the Children, The Hunger Project, and Vitamin Angels. The four groups and their areas of focus and objectives are as follows 'With our global reach, we are uniquely positioned to foster collaboration among these eight organizations. By leveraging our individual strengths and resources, we amplify our collective impact,' said Blaine Maxfield, managing director of Welfare and Self-Reliance Services. 'What a blessing it is to come together to serve God's children around the world.' The announcement of new funding was part of activities, including an expert panel discussion scheduled for later in the day on Thursday, June 5, led by Bishop L. Todd Budge, Second Counselor in the Church's Presiding Bishopric. The panel focused on health and nutrition for women and children. The panelists were President Camille Johnson, Blaine Maxfield, Sharon Eubank (director of Church Humanitarian Services), Sarah Bouchie (CEO of Helen Keller Intl), Ana Céspedes (CEO of Vitamin Angels), Lizz Welch (CEO of iDE), and Abena Amedormey (Ghana country representative for CRS). In 2023, the First Presidency asked the Relief Society to lead this global effort. President Russell M. Nelson has told women that they have a divine endowment to change lives. He said, 'I am inspired by your diligence, dynamic leadership, and your ability to see a need and meet it.' Members of The Church of Jesus Christ of Latter-day Saints believe in following the Savior's two great commandments: to love God and to love our neighbor. As part of this mandate, we seek to maximize our impact so our efforts bless not only those who receive help but also their families and communities. For more information on the Church's effort to care for those in need, please visit the most recent 'Caring for Those in Need' summary. View original content to download multimedia: SOURCE The Church of Jesus Christ of Latter-day Saints
Yahoo
a day ago
- Yahoo
This common prescription drug could reduce deaths by sepsis, study finds
Critically ill patients with sepsis who are given statins may be more likely to survive, new research suggests. Researchers set out to explore whether the cholesterol-busting drugs may bring additional benefits for patients. The new study examined information on sepsis patients who received statins during a stint in intensive care and compared it with patients in a similar situation who did not receive statins. Some 14.3 per cent of 6,000 sepsis patients who were given statins died within 28 days. This is compared with 23.4 per cent of 6,000 patients who did not receive statin therapy. The research team from China said that this equates to a 39 per cent reduced risk of death within a month. The research, based on data from thousands of patients at a hospital in Israel between 2008 and 2019, also found that 7.4 per cent of statin patients died while in the intensive care unit compared with 13.6 per cent of those who did not receive statins. And during their overall hospital stay, some 11.5 per cent of sepsis patients who were given statins died, compared with 19.1 per cent of sepsis patients who did not take statins. However, it appeared that those who were not prescribed statins had a slightly shorter hospital stay compared with those who did receive them – an average of eight days compared with almost 10 days. 'We found that statin users exhibited decreased 28-day all-cause mortality,' the authors wrote in the journal Frontiers in Immunology. Sepsis is a life-threatening reaction to an infection that occurs when the immune system overreacts and starts to damage the body's tissues and organs. In the UK, 245,000 people are affected by sepsis every year. UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored' as they called for larger trials to confirm the findings. Statins are known as cholesterol-busting drugs because they can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. But experts said that they also have other benefits, including reducing inflammation and antibacterial effects. The research team called for larger trials to confirm their findings. 'Our large, matched cohort study found that treatment with statins was associated with a 39 per cent lower death rate for critically ill patients with sepsis, when measured over 28 days after hospital admission,' said Dr Caifeng Li, the study's corresponding author and an associate professor at Tianjin Medical University General Hospital in China. 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Commenting on the study, Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.'
Yahoo
a day ago
- Yahoo
Statins can reduce sepsis deaths, study suggests
People who are critically ill with sepsis may be more likely to survive if they are given statins, a new study suggests. Researchers wanted to explore whether the cholesterol-busting drugs may bring additional benefits for patients. The new study examined information on sepsis patients who received statins during a stint in intensive care and compared it with patients in a similar situation who did not receive statins. Sepsis can be life-threatening, but knowing the signs can save lives. Symptoms differ in adults, children, & infants under 5. Learn more: — The UK Sepsis Trust (@UKSepsisTrust) January 7, 2025 Some 14.3% of 6,000 sepsis patients who were given statins died within 28 days. This is compared with 23.4% of 6,000 patients who did not receive statin therapy. The research team from China said that this equates to a 39% reduced risk of death within a month. The research, based on data from thousands of patients at a hospital in Israel between 2008 and 2019, also found that 7.4% of statin patients died while in the intensive care unit compared with 13.6% of those who did not receive statins. And during their overall hospital stay, some 11.5% of sepsis patients who were given statins died, compared with 19.1% of sepsis patients who did not take statins. However, it appeared that those who were not prescribed statins had a slightly shorter hospital stay compared with those who did receive them – an average of eight days compared with almost 10 days. 'We found that statin users exhibited decreased 28-day all-cause mortality,' the authors wrote in the journal Frontiers in Immunology. Sepsis is a life-threatening reaction to an infection that occurs when the immune system overreacts and starts to damage the body's tissues and organs. In the UK, 245,000 people are affected by sepsis every year. UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored' as they called for larger trials to confirm the findings. Statins are known as cholesterol-busting drugs because they can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. But experts said that they also have other benefits, including reducing inflammation and antibacterial effects. The research team called for larger trials to confirm their findings. 'Our large, matched cohort study found that treatment with statins was associated with a 39% lower death rate for critically ill patients with sepsis, when measured over 28 days after hospital admission,' said Dr Caifeng Li, the study's corresponding author and an associate professor at Tianjin Medical University General Hospital in China. 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Commenting on the study, Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.'
